Stock·NYSE·Industrials
Generac Holdings Inc. (GNRC)
- Market cap
- $11.18B
- P/E
- 43.50
- Dividend yield
- None
- Street target
- $284.00median of 22 analysts
- 52-week range
- $134.80 $296.44
GNRC stock forecast today
Where GNRC stands today, and what CleaRank Financial AI makes of it.
GNRC at a glance
Generac Holdings Inc. (GNRC): Hold, 51/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($200.14 and $217.64).
- Earnings GNRC beat estimates in 5 of the 6 reports in our data, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $22.5M and made no open-market purchases over the last 18 months.
- Valuation P/E of 43.5 against 34.0 for the Industrials sector: a premium to peers (+28%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Generac Holdings Inc. (GNRC) Hold, with a model score of 51/100.
The analysts' outlook lifts the score most: 16 of 22 analysts rate it a buy and the median target is 50.1% above the price. The trend holds it back most: the price is 13.05% below its 200-day average and 5.45% below its 50-day average, and the 50-day average is 8.04% below the 200-day. The 50-day average stands at $200.14 and the 200-day at $217.64. Over the past year the price fell 1.42%.
Only on CleaRank
Figures we compute ourselves from GNRC's own price, earnings and insider-filing history. Tap one to see it in context.
GNRC stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $189.23 is 5.4% below the 50-day simple moving average of $200.14.Price above its 200-day average ›
The price is 13.1% below the 200-day simple moving average of $217.64.50-day average above the 200-day ›
The 50-day average ($200.14) is 8.0% below the 200-day average ($217.64), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 34% of its 52-week range, between $134.80 and $296.44.
GNRC share price
Pick a period: each tab shows how far GNRC has moved over it, to the last close.
Today's trading
Where GNRC sits inside today's range and its 52-week range.
GNRC fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/4P/E below the sector median ›
The trailing P/E of 43.50 is 27.9% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 2.52 is 37.1% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $258.2M on revenue of $4.4B, a net margin of 5.8%.Beat estimates in most recent reports ›
GNRC beat the EPS estimate in 5 of the 6 reports in our data.
Key statistics
The headline figures for GNRC.
As of October 26, 2026, GNRC trades at $189.23, with a market value of $11.18B and a P/E ratio of 43.50.
What the numbers say
CleaRank Financial AI's reading of GNRC's valuation, growth and risks.
GNRC trades at a trailing P/E of 43.50, 27.9% above the Industrials median of 34.0, which the peer comparison on this page rates as a premium to peers. GNRC trades at 2.52 times its sales, 37.0% below the sector median of 4.0. GNRC has a market capitalisation of $11.2B and trailing earnings of $4.35 a share.
With revenue growth of 10.60%, GNRC is 1.1 percentage points slower than the sector median of 11.7%. GNRC turns sales into profit at a net margin of 5.82% and an operating margin of 17.93%, alongside a return on equity of 9.49%, below the sector median of 17.8%. The balance sheet rounds out the picture, with debt-to-equity of 0.49.
GNRC reported $2.91 per share against an estimate of $2.01 for the July 29, 2026 report, beating it by 44.78%. The stock still fell 1.68% in the first session after the report.
GNRC has beaten estimates in 5 of the 6 reports in our data, yet the stock still fell in the first session after 3 of those 5 beats. The July 30, 2025 report is the standout among the older results: EPS beat by 25.00%, and the stock rose 7.56% afterward. Analysts expect EPS of $9.71 this fiscal year and $12.97 next, with the current year showing growth of 53.2%.
Day-to-day volatility is the first thing to plan around: GNRC has moved 4.49% on an average session, and its beta against the S&P 500 is 1.92. The P/E of 43.50, 27.9% above the sector median, puts GNRC at a premium to peers, so weaker results would meet a higher bar. Until the price regains its moving averages, the trend works against holders. The price is 36.17% below its 52-week high of $296.44.
GNRC against the Industrials sector
How GNRC compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: GNRC trades at a significant premium to sector peers (+28%), suggesting market expectations for superior growth or market position.
Return vs XLI: Since May 14, 2025, GNRC has gained 47.3% against a gain of 18.8% for XLI.
Performance against XLI
GNRC and the Industrials sector fund over the same days.
Revenue and earnings
How much GNRC sells, and how much of it becomes profit.
Revenue growth: Revenue fell 2.0% in FY2025 to $4.2B, from $4.3B a year earlier.
Profit margin: The net margin was 3.8% in FY2025, down from 7.4% the year before.
Profitable: GNRC earned $161M in FY2025.
Earnings reality check
Did GNRC beat what analysts expected, and how did the stock react?
Earnings record: GNRC beat the analyst estimate in 5 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 29, 2026after close | $2.01 | $2.91 | +44.78% | -1.68% | +11.38% |
| Apr 29, 2026after close | $1.33 | $1.80 | +35.34% | +2.49% | +5.73% |
| Feb 11, 2026after close | $1.77 | $1.61 | -9.04% | +0.34% | +5.80% |
| Jul 30, 2025after close | $1.32 | $1.65 | +25.00% | +7.56% | +7.13% |
| Apr 30, 2025after close | $0.97 | $1.26 | +29.90% | -1.50% | +1.46% |
| Feb 12, 2025after close | $2.53 | $2.80 | +10.67% | -3.69% | -9.10% |
As of October 26, 2026, GNRC has beaten the analyst EPS estimate in 5 of the 6 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on July 29, 2026, came in 44.78% above the estimate and the stock moved -1.68% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
GNRC AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 40.8, in neutral territory.RSI above 50 ›
An RSI of 40.8 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of GNRC
The score, the reasoning behind it, and what could move the price next.
GNRC is in a downtrend: the price of $189.23 sits 13.05% below its 200-day average of $217.64 and 5.45% below its 50-day average of $200.14. Both averages point the same way, with the 50-day 8.04% below the 200-day. The price is at 34% of its 52-week range of $134.80 to $296.44, which leaves it 36.17% below the high.
The recent returns are all negative: the price fell 4.21% over the past three months, fell 14.10% over the past six months and fell 1.42% over the past year. The 14-day RSI of 40.8 is in the neutral zone, and the MACD line is negative.
New analyst coverage ›
Piper Sandler started coverage at Overweight on October 8, 2026.
Source: Analyst action, Piper Sandler, October 8, 2026Analyst upgrade ›
Keybanc upgraded it to Overweight from Sector Weight on October 8, 2026.
Source: Analyst action, Keybanc, October 8, 2026
Earnings beat, but the stock fell ›
The July 29, 2026 report beat the EPS estimate by 44.78%, and the share price fell 1.68% in the first session after it.
Source: Earnings report, July 29, 2026
- Two levels are closest to the price: the 50-day SMA at $200.14 sits above it, and the 52-week low at $134.80 sits below it.
- The 14-day RSI reads 40.8, in the neutral zone, with the MACD line negative; readings above 70 or below 30 mark stretched momentum.
- In the first session after the July 29, 2026 report, the share price dropped 1.68%, even though GNRC has beaten estimates in 5 of the 6 reports in our data.
GNRC sits below its 50-day and 200-day moving averages ($200.14 and $217.64), and that placement is why the trend reads down. Reclaiming the 50-day would be the first sign of repair. That average, at $200.14, is the nearest level above the current price.
The next level below the price is the 52-week low of $134.80.
Technical indicators
Momentum and trend for GNRC, from its daily closes.
As of October 26, 2026, with GNRC at $189.23, its 14-day RSI is 40.8 (neutral territory), its 50-day simple moving average is $200.14 and its 200-day is $217.64.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What GNRC moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, GNRC's 1-year correlation of daily returns is +0.49 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.21 with Bitcoin (BTC) and +0.17 with gold (XAU).
GNRC price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
3/3Most analysts rate it a buy ›
16 of 22 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $284.00 is 50.1% above the price.More buy ratings than three months ago ›
16 of 22 rate it a buy now, against 14 of 21 three months ago.
GNRC Wall Street View
12-month price targets
The price, $189.23, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | Piper Sandler | Initiates | Overweight |
| Oct 8, 2026 | Keybanc | Upgrade | Overweight |
| Oct 5, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Sep 30, 2026 | Citigroup | Maintains | Neutral |
| Sep 30, 2026 | Stifel | Maintains | Buy |
| Sep 18, 2026 | JP Morgan | Maintains | Overweight |
As of October 26, 2026, 22 Wall Street analysts cover GNRC: 16 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $215.00 to $375.00. The median GNRC price target is $284.00, 50.1% above the price of $189.23.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
GNRC trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
GNRC trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
GNRC moves about 4.5% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much GNRC tends to move, against the market and on its own.
GNRC price history and drawdowns
GNRC's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 4.49% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 83.3%, from October 2021 to October 2023; the price is still 62.0% below that peak.Most 1-year holds ended higher ›
73% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $49,407, against $42,015 in the S&P 500 (SPY).
GNRC Drawdowns & Recovery
As of October 26, 2026, GNRC's worst peak-to-trough fall over the last 10 years with dividends reinvested was -83.3% (October 2021 to October 2023); it is still 62.0% below that peak, and 73% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into GNRC in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: GNRC beat the S&P 500 over this period: $49,407 against $42,015.
A $10,000 investment in GNRC in October 2016 would be worth about $49,407 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to GNRC, and which have not.
Strongest month, July: an average of +8.87%, up in 9 of 10 years.
Weakest month, March: an average of -4.61%, up in 2 of 10 years.
This month, October: has averaged -0.76%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, GNRC's strongest calendar month has been July (average +8.87%, up in 9 of 10 years) and its weakest March (average -4.61%, up in 2 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
GNRC stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in GNRC, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in GNRC today could grow to about $14,511 by 2030 in the base case, with a 90th-percentile outcome near $47,697 and a 10th-percentile outcome around $4,415. Projections are statistical simulations, not guarantees.
GNRC Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $275 for GNRC by 2030 in the base case, from $189 today (1.5x over 4 years). The 10th-percentile path ends near $83.54. These are outcomes of a Monte Carlo simulation run on GNRC's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $115 | $208 | $377 | |
| 2028 | $98.27 | $228 | $529 | |
| 2029 | $89.27 | $250 | $701 | |
| 2030 | $83.54 | $275 | $903 |
Method: a lognormal simulation of GNRC's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
GNRC insider trading
What the people running the company have bought and sold.
GNRC insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: No insider bought GNRC shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
As of October 26, 2026, GNRC insiders reported 26 open-market sales worth $22.5M and no open-market purchases over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 6, 2026 | Norman P Taffe
Officer
|
Sell | 550 | $119.2K |
| Oct 6, 2026 | Norman P Taffe
Officer
|
Option | 250 | $29.9K |
| Oct 2, 2026 | Kyle Andrew Raabe
Officer
|
Sell | 603 | $128.2K |
| Oct 2, 2026 | Kyle Andrew Raabe
Officer
|
Option | 213 | $21.8K |
| Sep 8, 2026 | Norman P Taffe
Officer
|
Sell | 400 | $75.5K |
| Sep 8, 2026 | Norman P Taffe
Officer
|
Option | 100 | $12.0K |
| Sep 1, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $911.1K |
| Aug 7, 2026 | Kyle Andrew Raabe
Officer
|
Sell | 586 | $125.0K |
| Aug 7, 2026 | Kyle Andrew Raabe
Officer
|
Option | 213 | $21.8K |
| Aug 5, 2026 | Norman P Taffe
Officer
|
Sell | 550 | $120.4K |
| Aug 5, 2026 | Norman P Taffe
Officer
|
Option | 250 | $29.9K |
| Aug 3, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $974.5K |
| Jul 31, 2026 | Andrew G Lampereur
Director
|
Grant | 160 | $31.4K |
| Jul 31, 2026 | Bennett J Morgan
Director
|
Grant | 166 | $32.6K |
| Jul 31, 2026 | Dominick P Zarcone
Director
|
Grant | 128 | $25.1K |
| Jul 6, 2026 | Norman P Taffe
Officer
|
Sell | 550 | $140.8K |
| Jul 6, 2026 | Norman P Taffe
Officer
|
Option | 250 | $29.9K |
| Jul 1, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $1.4M |
| Jun 5, 2026 | Norman P Taffe
Officer
|
Sell | 550 | $149.7K |
| Jun 5, 2026 | Norman P Taffe
Officer
|
Option | 250 | $29.9K |
| Jun 1, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $1.4M |
| May 1, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $1.3M |
| May 1, 2026 | Marcia J Avedon
Director
|
Grant | 699 | $180.2K |
| May 1, 2026 | Kathryn V. Bohl
Director
|
Grant | 699 | $180.2K |
| May 1, 2026 | Robert D Dixon
Director
|
Grant | 699 | $180.2K |
| May 1, 2026 | William D Jenkins Jr
Director
|
Grant | 699 | $180.2K |
| May 1, 2026 | Andrew G Lampereur
Director
|
Grant | 820 | $211.4K |
| May 1, 2026 | Bennett J Morgan
Director
|
Grant | 825 | $212.7K |
| May 1, 2026 | David A Ramon
Director
|
Grant | 699 | $180.2K |
| May 1, 2026 | Dominick P Zarcone
Director
|
Grant | 796 | $205.2K |
| Apr 1, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $999.1K |
| Mar 5, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $1.1M |
| Feb 27, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Grant | 18.8K | - |
| Feb 27, 2026 | Rajendra Kumar Kanuru
General Counsel
|
Grant | 2.5K | - |
| Feb 27, 2026 | Kyle Andrew Raabe
Officer
|
Grant | 4.8K | - |
| Feb 27, 2026 | York A Ragen
Chief Financial Officer
|
Grant | 4.4K | - |
| Feb 27, 2026 | Norman P Taffe
Officer
|
Grant | 4.3K | - |
| Feb 27, 2026 | Erik Wilde
Officer
|
Grant | 2.5K | - |
| Feb 25, 2026 | York A Ragen
Chief Financial Officer
|
Sell | 24.4K | $5.7M |
| Feb 25, 2026 | Norman P Taffe
Officer
|
Sell | 2.0K | $470.6K |
| Feb 25, 2026 | York A Ragen
Chief Financial Officer
|
Option | 24.4K | $977.4K |
| Feb 25, 2026 | Norman P Taffe
Officer
|
Option | 1.0K | $124.3K |
| Feb 13, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Option | 109.1K | $3.6M |
| Feb 13, 2026 | Andrew G Lampereur
Director
|
Grant | 142 | $31.3K |
| Feb 13, 2026 | Bennett J Morgan
Director
|
Grant | 148 | $32.6K |
| Feb 13, 2026 | Dominick P Zarcone
Director
|
Grant | 114 | $25.1K |
| Feb 2, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $834.6K |
| Jan 2, 2026 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $689.9K |
| Dec 1, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $741.4K |
| Nov 3, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $832.2K |
| Nov 3, 2025 | William D Jenkins Jr
Director
|
Grant | 134 | $22.6K |
| Nov 3, 2025 | Andrew G Lampereur
Director
|
Grant | 171 | $28.9K |
| Nov 3, 2025 | Bennett J Morgan
Director
|
Grant | 178 | $30.0K |
| Nov 3, 2025 | Dominick P Zarcone
Director
|
Grant | 134 | $22.6K |
| Oct 1, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $837.1K |
| Sep 2, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $906.1K |
| Aug 1, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $946.8K |
| Aug 1, 2025 | William D Jenkins Jr
Director
|
Grant | 118 | $22.5K |
| Aug 1, 2025 | Andrew G Lampereur
Director
|
Grant | 151 | $28.8K |
| Aug 1, 2025 | Bennett J Morgan
Director
|
Grant | 158 | $30.2K |
| Jul 1, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $712.0K |
| Jun 5, 2025 | Aaron P Jagdfeld
Chief Executive Officer
|
Sell | 5.0K | $637.4K |
| Jun 5, 2025 | Kyle Andrew Raabe
Officer
|
Sell | 1.6K | $206.8K |
| May 2, 2025 | Marcia J Avedon
Director
|
Grant | 1.4K | $155.1K |
| May 2, 2025 | Kathryn V. Bohl
Director
|
Grant | 1.4K | $155.1K |
| May 2, 2025 | John D Bowlin
Director
|
Grant | 998 | $114.3K |
| May 2, 2025 | Robert D Dixon
Director
|
Grant | 1.4K | $155.1K |
| May 2, 2025 | William D Jenkins Jr
Director
|
Grant | 197 | $22.6K |
| May 2, 2025 | Andrew G Lampereur
Director
|
Grant | 1.6K | $183.9K |
| May 2, 2025 | Bennett J Morgan
Director
|
Grant | 1.6K | $185.0K |
| May 2, 2025 | Nam Tran Nguyen
Director
|
Grant | 1.4K | $155.1K |
| May 2, 2025 | David A Ramon
Director
|
Grant | 1.4K | $155.1K |
| May 2, 2025 | Dominick P Zarcone
Director
|
Grant | 1.6K | $177.6K |
Source: TwelveData, from SEC Form 4 filings
GNRC stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.